Profile | GDS5420 / 218799_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 641.78 | 71 |
GSM1296119 | B_lesional_pre-dose | 281.67 | 58 |
GSM1296076 | C_lesional_pre-dose | 425.42 | 66 |
GSM1296092 | D_lesional_pre-dose | 794.46 | 75 |
GSM1296103 | E_lesional_pre-dose | 845.42 | 76 |
GSM1296078 | F_lesional_pre-dose | 368.18 | 64 |
GSM1296107 | G_lesional_pre-dose | 356.71 | 62 |
GSM1296109 | H_lesional_pre-dose | 624.47 | 71 |
GSM1296080 | I_lesional_pre-dose | 623.19 | 71 |
GSM1296090 | J_lesional_pre-dose | 527.37 | 69 |
GSM1296074 | K_lesional_pre-dose | 615.11 | 72 |
GSM1296111 | L_lesional_pre-dose | 314.9 | 60 |
GSM1296099 | M_lesional_pre-dose | 599.14 | 70 |
GSM1296086 | O_lesional_pre-dose | 698.52 | 73 |
GSM1296117 | P_lesional_pre-dose | 418.94 | 64 |
GSM1296113 | Q_lesional_pre-dose | 349.75 | 61 |
GSM1296096 | R_lesional_pre-dose | 622.3 | 71 |
GSM1296105 | S_lesional_pre-dose | 373.75 | 62 |
GSM1296098 | T_lesional_pre-dose | 503.01 | 68 |
GSM1296101 | U_lesional_pre-dose | 492.27 | 67 |
GSM1296121 | V_lesional_pre-dose | 341.93 | 61 |
GSM1296088 | W_lesional_pre-dose | 590.48 | 70 |
GSM1296082 | X_lesional_pre-dose | 725.25 | 74 |
GSM1296115 | Y_lesional_pre-dose | 349.95 | 61 |
GSM1296084 | Z_lesional_pre-dose | 653.37 | 72 |
GSM1296072 | B_lesional_day8 | 244.04 | 55 |
GSM1296069 | L_lesional_day8 | 279.16 | 57 |
GSM1296071 | P_lesional_day8 | 240.61 | 54 |
GSM1296070 | Y_lesional_day8 | 310.39 | 59 |
GSM1296073 | V_lesional_day8 | 377.4 | 63 |
GSM1296034 | A_lesional_day15 | 299.74 | 58 |
GSM1296041 | G_lesional_day15 | 272.42 | 57 |
GSM1296035 | R_lesional_day15 | 590.21 | 70 |
GSM1296038 | U_lesional_day15 | 487.1 | 67 |
GSM1296047 | B_lesional_day15 | 249.39 | 55 |
GSM1296039 | E_lesional_day15 | 466.9 | 67 |
GSM1296042 | H_lesional_day15 | 272.17 | 57 |
GSM1296043 | L_lesional_day15 | 251.49 | 55 |
GSM1296037 | M_lesional_day15 | 331.99 | 60 |
GSM1296046 | P_lesional_day15 | 213.26 | 52 |
GSM1296044 | Q_lesional_day15 | 257.14 | 55 |
GSM1296045 | Y_lesional_day15 | 314.08 | 59 |
GSM1296025 | C_lesional_day15 | 376.19 | 63 |
GSM1296033 | D_lesional_day15 | 423.02 | 65 |
GSM1296027 | I_lesional_day15 | 350.3 | 62 |
GSM1296032 | J_lesional_day15 | 404 | 64 |
GSM1296024 | K_lesional_day15 | 307.5 | 60 |
GSM1296031 | W_lesional_day15 | 418.96 | 64 |
GSM1296028 | X_lesional_day15 | 523.97 | 68 |
GSM1296029 | Z_lesional_day15 | 450.25 | 66 |
GSM1296026 | F_lesional_day15 | 461.13 | 67 |
GSM1296030 | O_lesional_day15 | 838.81 | 76 |
GSM1296040 | S_lesional_day15 | 588.99 | 70 |
GSM1296036 | T_lesional_day15 | 392.71 | 63 |
GSM1296048 | V_lesional_day15 | 382.94 | 63 |
GSM1296059 | A_lesional_day43 | 638.11 | 72 |
GSM1296066 | G_lesional_day43 | 304.06 | 59 |
GSM1296060 | R_lesional_day43 | 425.73 | 65 |
GSM1296063 | U_lesional_day43 | 333.84 | 61 |
GSM1296064 | E_lesional_day43 | 498.13 | 68 |
GSM1296067 | H_lesional_day43 | 276.19 | 56 |
GSM1296062 | M_lesional_day43 | 539.49 | 68 |
GSM1296068 | Q_lesional_day43 | 252.48 | 54 |
GSM1296050 | C_lesional_day43 | 318.73 | 61 |
GSM1296057 | D_lesional_day43 | 503.05 | 67 |
GSM1296052 | I_lesional_day43 | 498.63 | 68 |
GSM1296054 | J_lesional_day43 | 461.71 | 66 |
GSM1296049 | K_lesional_day43 | 351.22 | 62 |
GSM1296055 | W_lesional_day43 | 402.66 | 64 |
GSM1296053 | X_lesional_day43 | 588.63 | 70 |
GSM1296058 | Z_lesional_day43 | 659.93 | 72 |
GSM1296051 | F_lesional_day43 | 318.55 | 61 |
GSM1296056 | O_lesional_day43 | 711.01 | 74 |
GSM1296065 | S_lesional_day43 | 290.51 | 58 |
GSM1296061 | T_lesional_day43 | 413.41 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 444.57 | 66 |
GSM1296120 | B_non-lesional_pre-dose | 273.79 | 57 |
GSM1296077 | C_non-lesional_pre-dose | 395.77 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 491.63 | 67 |
GSM1296104 | E_non-lesional_pre-dose | 465.14 | 67 |
GSM1296079 | F_non-lesional_pre-dose | 396.82 | 64 |
GSM1296108 | G_non-lesional_pre-dose | 273.16 | 57 |
GSM1296110 | H_non-lesional_pre-dose | 301.38 | 58 |
GSM1296081 | I_non-lesional_pre-dose | 376.59 | 63 |
GSM1296091 | J_non-lesional_pre-dose | 465.97 | 67 |
GSM1296075 | K_non-lesional_pre-dose | 420.51 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 222.74 | 52 |
GSM1296100 | M_non-lesional_pre-dose | 494.77 | 67 |
GSM1296087 | O_non-lesional_pre-dose | 661.75 | 72 |
GSM1296118 | P_non-lesional_pre-dose | 206.14 | 51 |
GSM1296114 | Q_non-lesional_pre-dose | 269.47 | 56 |
GSM1296097 | R_non-lesional_pre-dose | 295.34 | 59 |
GSM1296106 | S_non-lesional_pre-dose | 323.37 | 59 |
GSM1296102 | U_non-lesional_pre-dose | 436.37 | 64 |
GSM1296122 | V_non-lesional_pre-dose | 294.56 | 58 |
GSM1296089 | W_non-lesional_pre-dose | 560.25 | 69 |
GSM1296083 | X_non-lesional_pre-dose | 254.63 | 56 |
GSM1296116 | Y_non-lesional_pre-dose | 263.39 | 55 |
GSM1296085 | Z_non-lesional_pre-dose | 376.42 | 63 |